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Abstract
Despite the continually increasing rates of adverse perinatal outcomes across the globe, the molecular mechanisms that
underlie adverse perinatal outcomes are not completely understood. Clinical studies report that 10% of pregnant women
will experience a urinary tract infection (UTI) and there is an association of UTIs with adverse perinatal outcomes. We
introduced bacterial cystitis into successfully outbred female mice at gestational day 14 to follow pregnancy outcomes and
immunological responses to determine the mechanisms that underlie UTI-mediated adverse outcomes. Outbred fetuses
from mothers experiencing localized cystitis displayed intrauterine growth restriction (20–80%) as early as 48 hours post-
infection and throughout the remainder of normal gestation. Robust infiltration of cellular innate immune effectors was
observed in the uteroplacental tissue following introduction of UTI despite absence of viable bacteria. The magnitude of
serum proinflammatory cytokines is elevated in the maternal serum during UTI. This study demonstrates that a localized
infection can dramatically impact the immunological status as well as the function of non-infected distal organs and tissues.
This model can be used as a platform to determine the mechanism(s) by which proinflammatory changes occur between
non-contiguous genitourinary organs
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Introduction
Adverse perinatal outcomes include both prematurity (birth
prior to 37 weeks) and/or low birthweight (weight below 2500
grams). There is a discernible etiology in only 50% of adverse
perinatal outcomes [1]. The primary known causes of adverse
outcomes include multiple gestation [2], high blood pressure [3],
diabetes mellitus [4], intrauterine infection [5], pneumonia [6,7],
periodontal disease [8,9] and UTI [10,11]. Premature and low
birthweight neonates have increased rates of morbidity and
mortality in the first year of life and suffer from a plethora of
life-long health conditions including: neurological, respiratory,
gastrointestinal, cardiovascular, and immunological [12,13].
These health conditions are more severe when the mother
experiences infections during pregnancy [14].
Pregnancy is a unique situation in which the fetus carries both
maternal (‘‘self’’) and paternal (‘‘non-self’’) antigens. While the
immune system normally functions to attack non-self stimuli,
successful gestation requires the maternal immune response to
‘‘ignore’’ paternal antigens produced by the fetus (termed: fetal
tolerance). While mechanisms of tolerance between mother and
fetus are not completely understood, it is clear that dendritic cells
(DCs), T cells and natural killerd (NK) cells play crucial roles at the
maternal-fetal interface and in maternal tissues to ensure that
pregnancy proceeds successfully [15]. Immature dendritic cells
(iDCs) migrate from the uterus to local lymph nodes during
pregnancy to induce T cell differentiation into Th2/3 and
regulatory T cells (Treg). Th2/3 cells prevent maternal immune
responses from attacking the developing outbred fetus to maintain
healthy pregnancies [15].
Maternal infections contribute to nearly 40% of all adverse
perinatal outcomes [13]. Murine models have begun to illuminate
immunological changes that lead to adverse perinatal outcomes
due to maternal intrauterine infection [16,17,18]. Various cellular
and soluble immune effectors are known to contribute to fetal
tolerance and thus, a successful pregnancy. However, these same
effectors may negatively affect the developing fetus in the presence
of a pro-inflammatory stimulus (e.g. infection). For example,
interferon gamma (IFN-c) and tumor necrosis factor (TNF)
promote DC maturation in response to an inflammatory/
infectious stimulus [15]. Thus, mature DCs (mDCs) may travel
systemically and, in the presence of IL-12, induce T cell
differentiation into Th1 type cells [15]. Th1 cells then produce
IL-12, IFN-c and TNF, which result in an inflammatory,
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33897unfavorable environment for a developing fetus [15]. Local
intrauterine infections may elicit sufficient inflammatory cytokines
that recruit inflammatory cells and thus promote an inhospitable
intrauterine environment [19,20]. However, mechanisms by
which localized extrauterine infection, such as UTIs, cause low
birthweight and/or preterm birth are unknown.
UTIs affect almost 50% of all women (10% of pregnant women)
and manifest in a variety of clinical presentations (i.e., asymptom-
atic bacteriuria, cystitis, and pyelonephritis) [19]. While many
UTIs generally have a mild clinical course with few sequelae in the
general population, even asymptomatic bacteriuria places the
gestating female at risk for low birthweight offspring and preterm
birth [20,21,22,23,24,25,26]. These studies suggest that UTIs act
as an independent risk factor for preterm delivery and intrauterine
growth restriction-low birthweight (IUGR-LBW) [27].
There is a long-standing murine model for UTIs caused by
uropathogenic Escherichia coli (UPEC) that has been extensively
studied to determine the molecular details of UTI pathogenesis
(see recent reviews [28,29]). Observations made with the mouse
model have been confirmed in human urine samples and biopsies
of patients infected with UPEC [28,30,31,32,33], which validates
this as an appropriate model for human UTI. We hypothesize that
a cascade of immunological events occurs in response to a UTI
that affects nearby but uninfected organs such as the uteropla-
cental unit. To this end, we developed a novel murine model for
UTI-mediated adverse perinatal outcomes (i.e., IUGR-LBW) and
analyzed cellular and soluble immune effectors that contribute to
perinatal morbidity.
Results
Maternal UTI results in low-birth weight offspring
We selected inbred C57Bl/6J females (MHC haplotype b) for
mating with inbred CH3/HeN males (MHC haplotype k) to
produce outbred fetuses (see Methods and Materials for detailed
discussion of the mating). Experimental UTI was established in
pregnant mice 14 days after conception, as previously described
[34](see Methods and Materials). The genitourinary tissues, fetuses
and blood from pregnant mice were harvested at gestational days
16, 18 and after natural parturition (48 hours, 96 hours and
144 hours post infection, respectively). The weight of each
offspring was measured on the day of harvest. There was no
difference in the viability of the offspring in either experimental
cohort either experimental cohort of the fetuses prior to delivery or
of the pups observed. Viability was accessed by observation of
visible independent movement of each fetus or pup within a given
litter. Sham treated mice fostered more robust fetal growth than
the mothers that received experimental UTI (Figure 1). At
48 hours post-infection, the median fetal weight from mothers
that experienced sham infection was 0.617060.122 g, while the
median fetal weight from mothers with UTI was significantly
lower (0. 41760.165 g) (p=0.0008). Fetal weight gain was
observed over the next 48 hours in most mothers, but the median
remained stunted at 96 h in the experimental UTI cohort
(1.09360.108 g vs 1.00460.175 g) (p=0.0002). The greatest
disparity in fetal weight was observed at delivery. After natural
parturition, the median pup weight from mothers that experienced
experimental UTI was 1.09060.404 g, which was significantly
lower than the median pup weight of 1.40060.08 g from mothers
who received sham treatment (p,0.0001). The severity of IUGR
is most likely underestimated for the final two days of gestation as
mice typically consume pups with weights less than 0.5 g. In fact,
the number of pups was significantly different at the time of
delivery (Figure 1), although the number of implantation sites was
not different (median number of sites, n=8 for both cohorts,
p=1.0), indicating that the same number of fetuses arose from the
conception (data not shown). All mothers gained weight at similar
rates and pups were delivered at 20 days (Figure S1). Therefore,
the changes in offspring weight cannot be attributed to differences
in maternal weight gain or gestational length. Thus, the
experimental evidence strongly suggests that IUGR and LBW
are the direct consequence of maternal UTI.
Cystitis remains localized during pregnancy
The genitourinary tissues, fetus and blood from pregnant mice
were cultured for viable UPEC to determine the tissue
Figure 1. Perinatal outcomes in the presence and absence of maternal UTI. (A) Weight (grams) of each individual offspring from pregnant
mice that received sham treatment (white) or experimental UTI (gray) at 48 h (10 mice each cohort), 96 h (10 mice each cohort), and delivery (8 mice
each cohort). Box portion of the plot represents 95% of the samples with the range of samples indicated by the external bars; the horizontal bar
within the box depicts the median and the mean values are indicated in the text. (B) The number of pups delivered for each mother is depicted.
Statistical significance was determined using a two-tailed Mann-Whitney test for internal comparisons of each time point indicated in each panel.
doi:10.1371/journal.pone.0033897.g001
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tract. No bacteria were detected in any of the tissues analyzed
from sham-treated mice. Viable bacteria were present throughout
pregnancy and parturition in the bladders of mothers that
received UPEC (Table 1). The bacterial burden at the later time
points is indicative of a latent infection [35,36,37]. Viable
bacteria were not detected in the kidneys from mice that were
given experimental cystitis, indicating that the urinary tract
infection was restricted to the lower tract (bladder) throughout
pregnancy. No viable bacteria were detected within the
uteroplacental tissue, blood, and fetal tissues (Table 1), indicating
that UPEC did not disseminate systemically and that other
bacterial species did not gain access to the reproductive organs or
the fetuses. Thus, the fetal detriment detailed above is likely not
due to the direct bacterial invasion of the uteroplacental tissue
observed with other models, but rather is the result of an
inflammatory response disseminated to the uterus via cellular
and/or soluble immune effectors.
Influx of Polymorphonuclear neutrophils (PMNs) and
Macrophages in the bladder during UTI
Although several laboratories, including ours [38,39,40] have
described the infiltration of both PMNs and macrophages into the
bladder during cystitis, the extent of phagocytic recruitment to the
bladder of a pregnant mouse is not well characterized. We next
evaluated the magnitude and types of proinflammatory cells
recruited to the bladder during experimental UTI in pregnant
mice. We initially sought to analyze the bacterial burden, myeloid
infiltrate and lymphoid infiltrate in each of the genitourinary
tissues. Under our experimental conditions, the samples were
divided for three separate quantitative analyses (bacterial burden,
myeloid cells, lymphoid cells). We successfully enumerated
bacteria (Table 1) and myeloid cells (Figure 2). However, we did
not detect a significant magnitude of lymphoid cell recruitment
within the portions of the tissue examined at the selected time
points (data not shown). At 48 hours post-infection (gestational day
16), both PMNs (CD11b
+, Gr-1
+hi, Ly6C
+, F4/80
2) and
macrophages (CD11b
+,Gr-1
+low, Ly6C
+ F4/80
+) (Figure S2) were
elevated in the bladder of infected pregnant mice compared to
sham-treated pregnant mice (Figure 2). At 96 hours post-infection
(gestational day 18), the number of phagocytic cells increased
significantly [PMNs (p=0.05) and macrophages (p=0.03)] in the
bladder. After the mothers went through natural parturition, the
magnitude of both PMNs and macrophages diminished. The
magnitude of inflammation remained constant despite a decrease
in the bacterial burden at the later time points. The magnitude of
PMN infiltrate is greater in the bladder of pregnant mice than in
non-pregnant mice [40], further suggesting that pregnancy
produces a distinct inflammatory environment in response to an
extrauterine infection (i.e., UTI).
Influx of PMNs and macrophages in other genitourinary
tissues during UTI
We next evaluated whether the induction of localized cystitis in
the bladder would elicit a cellular immune response in adjacent
genitourinary tissues. Renal tissue demonstrates a similar cellular
pro-inflammatory infiltrate as observed in the bladder (Figure 2),
despite the lack of viable UPEC in the organ (Table 1). The
magnitude of both PMNs and macrophages increased over time
and reached significance on gestational day 18 (96 hours post-
UTI) (p=0.02 and p=0.04, respectively). With respect to the
uterus, we observed a statistically significant change in infiltration
of PMNs and macrophages throughout the last week of gestation
(Figure 2; note change in scale of y axis). The magnitude of
infiltration of PMNs into the uteroplacental tissue was inversely
correlated with fetal weight at 96 h post infection (Figure S3). On
gestational day 18 (96 hours post-UTI) the magnitude of PMNs
and macrophages was significantly greater in the cohort that
received experimental UTI when compared to the sham cohort
(p=0.02 and 0.01 for PMNs and macrophages, respectively). On
the morning following natural delivery (gestational day 20), the
difference in PMN and macrophage infiltration into the uterus
lessened due to increased infiltration in the sham treated group
(Figure 2). Phagocytic influx into uterus at parturition has been
previously demonstrated [41]. Sukhikh et al. suggested a functional
role for phagocytes during and after the natural course of
parturition. We observed a difference in the magnitude of PMN
and macrophage infiltration between the uteroplacental tissue and
the non-pregnant uterus (data not shown), suggesting that
pregnancy presents a unique situation, which may promote
proinflammatory immune responses in the presence of infection.
Interestingly, our results indicate that inflammation-associated
cellular effectors are present in tissues that lack UPEC coloniza-
tion, (e.g. uteroplacental tissue) suggesting that either soluble
bacterial factors or transient host-derived mediators result in such
an inflammatory environment.
Mature dendritic cells (mDC) increase during UTI
The maturation state of DCs dictates the success or failure of
outbred pregnancies [42]. In this study, we detected a statistically
significant increase in the magnitude of mDCs (CD11c
+, MHC
II
+med-hi) in the bladders of infected mice 48 and 96 hours post-
infection (gestational day 16 and 18, respectively) (Figure 3). The
presence of mDCs in the uterus indicates that inflammatory signals
have expanded beyond the bladder and initiation of adaptive
immunity has occurred (i.e., uterine mDCs). Interestingly, the
percentage of iDCs, (CD11c
+, MHC II
+lo) which are important for
maintenance of fetal tolerance, remained unchanged in uteropla-
cental tissues at all of the post-infection time points analyzed
(Figure 3). The similar levels of iDCs suggest that, at least, portions
of fetal tolerance are intact in the presence of maternal UTI. In
addition, our data suggest that mDCs may have matured
elsewhere (e.g., bladder) and may have trafficked to the uterus
upon infection of the urinary.
Serum cytokines are elevated during maternal UTI
As serum levels of pro-inflammatory cytokines are elevated
during UTI [33], we were interested to determine whether specific
cytokines are associated with maternal UTI-mediated IUGR-
LBW. Serum was collected from sham-treated and experimental
UTI cohorts at the time of tissue harvest for evaluation of
Table 1. Bacterial burden of the bladder, kidney, and uterus
of infected mothers at 48 h, 96 h, and delivery are reported as
colony forming units (CFUs) per individual organ with the
standard deviation.
Time Bladder Kidney Uteroplacental Blood Fetus
48 hour 6610
5+670 N.D. N.D. N.D. N.D.
96 hour 4610
4+3887 N.D. N.D. N.D. N.D.
Delivery 1610
4+22 N.D. N.D. N.D. N.D.
N.D.=not detected (Limit of detection is 10
3 cfu).
doi:10.1371/journal.pone.0033897.t001
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Methods. While cytokines were elevated in the experimental UTI
cohort as compared with the sham cohort at 48 hours, none of the
individual comparisons reached statistical significance (data not
shown). Circulatory pro-inflammatory cytokines were greater in
mothers experiencing experimental UTI than in those mothers in
the sham cohort at 96 hours post-introduction of UTI and at
parturition (Figure 4). At 96 hours post introduction of infection,
only the values for IL-6 were significantly greater in mothers that
received experimental UTI compared to mothers in the sham
cohort (p=0.0028) (Fig. 4). When the magnitude of serum IL-6
was correlated to the weight of each individual fetus at 96 h post
infection, the highest levels of IL-6 were observed in those infected
mothers with the lowest weight offspring (Figure S4). At delivery,
the magnitude of IL-6 remained significantly elevated (p=0.001)
as well as the magnitude of IL-4 (p=0.04), IL-10 (p=0.03), INF-c
(p=0.008) and IL-17 (p=0.0003) (Figure 4). These data
demonstrate that a robust systemic immunological response, as
measured by the magnitude of serum cytokines, occurs down-
stream of maternal UTI at a time when the bacteria have
transitioned from the acute to the latent infection [35,36,43].
Transcriptional changes in placenta resulting from
maternal UTI
In order to identify early changes in the placenta that lead to
fetal demise, we compared transcriptional changes in the presence
and absence of experimental UTI. Placenta and uterus were
harvested on gestational day 16 (48 hours post UTI) from mice
from the sham cohort and mice from that received experimental
UTI on gestational day 14. The tissue samples were processed for
extraction of mRNA and subjected to Agilent microarray analysis
(Methods and Materials). There were no significant differences in
the transcriptional profiles between the uterus tissue in the
presence or absence of infection (data not shown). Within the
placental tissues, there were 257 transcripts that ranged in
differential expression values ranging from 4.7–810 fold
(Table 2)(full raw data deposited into the MIAME compliant
GEO database, accession GSE32028). Cathepesin Q, as well as a
number of other apoptotic factors, demonstrated robust increase
in expression (up to 810 fold) in the presence of maternal UTI.
Placental levels of prolactin were also significantly increased in the
presence of maternal UTI. There was an increase in the
expression of the leptin receptor in the placenta of mothers that
Figure 2. PMN and macrophage infiltration in uteroplacental tissues. The magnitude of the particular cell type of interest is reported as a
percentage of live leukocytes within each individual organ indicated from pregnant mice that received sham infection (white) or experimental UTI
(gray) at 48 h (10 mice each cohort), 96 h (10 mice each cohort), and delivery (8 mice each cohort). Abbreviations: PMN, polymorphonuclear
neutrophil; Mac, macrophage. Bars indicate standard deviation. Statistical significance determined using a two-tailed Mann-Whitney for internal
comparisons within each time point indicated in each panel.
doi:10.1371/journal.pone.0033897.g002
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transcriptional analysis were directly related to activation or
recruitment of the innate immune response (e.g. TRL receptor,
cytokine production, chemokine production), which corroborates
the observation that the reproductive organ is sterile. Furthermore,
the lack of primary inflammatory mediators suggests that bacterial
antigens do not appear to escape the bladder to gain access to the
reproductive organ to initiate the proinflammatory responses
observed in the uteroplacental unit.
Discussion
Here, we demonstrate that a non-disseminated UTI is
associated with adverse perinatal outcomes. Kaul et al. presented
a mouse model of pyelonephritis-induced preterm birth and low
birth weights while investigating the virulence of the Dr adhesion
[44]. In contrast to our model, the mothers became septic and all
of the fetuses became infected, presumably due to the use of a
pyelonephritic UPEC strain (compared to our cystitis strain) and
the use of immunocompromised TLR4-deficient mothers. Due to
the dissemination to the reproductive organ, the model presented
by Kaul et al. provides additional insight into the effects of
intrauterine infection on fetal development. In our system, the
offspring of mothers that experienced experimental UTI displayed
up to 80% decrease in fetal weight when compared to non-infected
mothers. This phenomenon occurs as early as 48 hours post
introduction of cystitis and continues throughout gestation. An
important feature of our model of adverse perinatal outcome
model is that localized cystitis induced delayed infiltration of
PMNs and macrophages in distal organs. We demonstrated that
bladders from mice with experimental UTI had an expected
increase of professional phagocytes as a result of localized
infection; however, inflammatory cells were also observed in the
kidney, even in the absence of viable bacteria. Furthermore, a
Figure 3. Presence of dendritic cells in uteroplacental tissues. The magnitude of the particular cell type of interest is reported as a percentage
of live leukocytes within each individual organ indicated from pregnant mice that received sham infection (white) or experimental UTI (gray) at 48 h
(10 mice each cohort), 96 h (10 mice each cohort), and delivery (8 mice each cohort. Statistical significance determined using a two-tailed Mann
Whitney for internal comparisons within each time point, no significance observed. Abbreviations: mDC, mature dentritic cell; iDC, immature
dendritic cell.
doi:10.1371/journal.pone.0033897.g003
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uteroplacental tissue of those mice with experimental UTI when
no viable bacteria were recovered (the same tissue sample tested
for both bacteria and cellular infiltrate). In fact, there was a
correlation between PMN infiltration and diminished fetal weight
gain (Figure S3), suggesting that the presence of the PMNs may
contribute to the IUGR-LBW observed in the presence of non-
disseminated UTI. The cellular inflammatory response in the
pregnant reproductive organ was more severe than the kidney and
in the naı ¨ve uterus, suggesting that the uteroplacental tissue is no
longer privileged and may be more susceptible than other adjacent
genitourinary organs to systemic changes in immune status.
Our evidence indicates that the placenta is progressing through
apoptotic death as a consequence of a strong cellular influx of
immune cells into the reproductive organ. Cathepsin Q is a
placental specific apoptotic factor that induces necrotic cell death
in the presence of reactive oxygen species-mediated DNA damage
such as produced by PMNs and macrophages. We hypothesize
that the induction of Cathepsin Q in the UTI cohort indicates that
the influx of professional phagocytes is inducing DNA damage
within the placental cells. High serum prolactin is associated with
miscarriage in humans [45] and prolactin is involved in the T-cell
functions associated with maintenance of fetal tolerance [46].
Whether prolactin levels are elevated as a consequence of the
phagocyte infiltration as a means to protect the fetus from the
maternal immune response or whether the levels disrupt the T-cell
functions that lead to inflammatory cell infiltrate are under
investigation. Leptins are important in proper fetal weight gain
[47]. The increased production of the leptin receptor suggests that
the placental unit is attempting to acquire more nutrition for the
developing fetus. These observations provide insight into the
molecular mechanisms that underlie intrauterine growth restric-
tion as a result of maternal UTI.
Cytokines measured in the serum of our infected pregnant
females demonstrated the absence of Th2 effectors characteristic
for healthy pregnancy, and thus, both Th1 cytokines (INF-c, TNF-
a) and Th17 cytokines (IL-17) are significantly elevated at delivery.
Furthermore, IL-6 and TGF-b are key factors in the development
of Th17 cells. Similar systemic inflammation along with an
imbalance of Th1 and Th2 cells in the uterus is a dominant
component implicated in the pathogenesis of pre-eclampsia [48].
This change from Th2 to Th1 should alter DC function and
compromise fetal tolerance. However, we did not detect significant
changes in uteroplacental iDCs, thus, we favor the hypothesis that
mDCs may traffic to adjacent organs via hematogenous route.
Multiple mechanisms by which DCs can mobilize to lymph node
or spleen, return to the blood and enter other organs were
reviewed by Randolph et al. [49]. Reverse trafficking might
facilitate the spread of antigens from tissue to tissue carried by DCs
serving as Trojan horses [50,51]. However, our transcriptional
analysis of the placenta indicates that the placenta is not the
primary site of immune activation under these experimental
conditions. It is also possible that cellular innate responses result in
increased levels of cytokines such as TNF-a that could stimulate
DC maturation in distinct and distant urogenital tissues, which
would in turn, promote Th1/Th17 responses and manifest in a
more robust systemic inflammation. Indeed, we were able to
detect an increase in mDC in the uteroplacental tissue, and also
elevated inflammatory cytokines in the serum, which might impact
the type and severity of the inflammatory responses. The
implication of a remote infection producing sufficient inflamma-
tory stimuli to restrict adequate fetal development has numerous
clinical implications. Moreover, these observations suggest that
local infections result in the inflammation in a number of non-
infected organs, which may also impact the function of those
organs. In this particular case, the systemic inflammation has a
dramatic effect on an organ function (i.e. the uteroplacental unit)
leading to intrauterine growth restriction and low birth weight.
Figure 4. Serum cytokine profiles during pregnancy and UTI. The magnitude of serum cytokines (pg/ml) of cytokines at 96 h (A) and delivery
(B) of mothers that received sham infection (white) or experimental UTI (gray). The serum taken from each individual mouse is measured separately.
The number of mice used in each cohort at 96 h and delivery were 10 and 8, respectively. Statistical significance was determined using two-tailed
Mann-Whitney (**, p,0.04; ***, p,0.008; ****, p=0.0003).
doi:10.1371/journal.pone.0033897.g004
Table 2. The top 4 families that demonstrate increased
transcription in each individual placenta at 48 hours following
introduction of maternal UTI are indicated, along with the
number of times each family was represented and the fold
change in expression.
Family Function Occurrences Fold Increase
Cathepsin Apoptosis 6 81–810
Prolactin Maintain fetal tolerance 22 28–784
Leptin receptor Fetal weight gain 9 71–93
Ceacam Cell adhesion 5 56–568
The full list of transcripts is deposited in the GEO database (accession number
GSE32028).
doi:10.1371/journal.pone.0033897.t002
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UTI-induced adverse perinatal outcomes provides a platform to
further elucidate the inter-organ cross talk that occurs during
localized infections.
Materials and Methods
Mice and optimized mating for generation of outbred
pregnancies
4–6 week old C57Bl/6 female mice were obtained from
Jackson Lab, (Bar Harbor, ME). Females were outbred with
C3H/HeN males less than 1 year of age purchased from Harlan
Labs (Indianapolis, IN). Forty-eight hours prior to the overnight
mating sessions, males and females were exchanged in the cages
to allow the mice to become familiar with their future mate’s
scent in an attempt to increase the rate of conception. To
synchronize impregnation and maintain precise infection and
delivery dates, 2 females were housed with 1 male (in the
female’s cage) overnight for less than 16 hours. Therefore,
successful pregnancies were determined by maternal weight gain
following cohousing. Female mice that did not become pregnant
as determined by every other day weight measurements were
returned to the mating rotation every 2–3 weeks until
conception occurred. Females were deemed pregnant if they
had gained at least 2 grams over a 1-week period. The distinct
histocompatibility complex classes chosen will invoke fetal
tolerance to prevent fetal rejection. Our mating combination
resulted in the typical number of fetuses with a gestational
length of 20 days (Figure S1). With this mating pair
combination, we observed a normal distribution of fetus number
(8–10) and gestational length (typically 19–21 days). Taken
together with an average rate of impregnation of 30%, these
variables indicate that maternal fetal tolerance prevented
rejection of the paternal allo-antigens resulting in a successful
pregnancy. The presence of fetal tolerance in our outbred model
is further supported by other investigations that demonstrate
f e t a lr e j e c t i o nu s i n gad i f f e r e n toutbred mating pair that does
not invoke fetal tolerance [52,53]. Maintenance of all mice was
in strict accordance of the Institutional Animal Care and Use
Committee (IACUC) rules and regulations. All animals are
housed in accordance with USDA guidelines for the care and
housing of laboratory animals, and USDA officials routinely
inspect the facilities. Specifically, the mice had a normal 12-
hour light-dark cycle and were maintained on standard chow
diet (Harlan Laboratories). The mice were housed using
ventilated cages, corncob bedding, and proper enrichment with
changes on a two-week basis. As such, at most, the cages were
changed once during the experimental period. The mice were
also sequestered from being inadvertently disturbed by human
interactions due to housing in a separate containment unit that
was only opened when the pregnant mice were monitored. The
experiments presented in this manuscript are approved (AR08-
00039) by The Research Institute at Nationwide Children’s
Hospital Institutional Laboratory Animal Care and Use
Committee (Welfare Assurance Number A3544-01).
Infection/Bacterial Strains
UTI89/pANT4 [43,54], a prototypical UPEC strain obtained
from a patient with cystitis [35] which contains an episomal
plasmid asserting ampicillin resistance, was used for all studies.
Pregnant female mice were transurethrally inoculated with 50 ml
of ,10
8/mL UTI89/pANT4 or sterile phosphate buffered saline
(PBS) as previously described [34].
Tissue Processing
Following isoflurane anesthesia per IACUC protocols, renal
arteries of the pregnant mice were severed and blood was aspirated
into tubes containing EDTA. Bladder, kidneys, and uteroplacental
tissues were minced into small pieces withscissors and were digested
for 25–30 minutes at 37uC under slight agitation. Bladders and
kidneys were digested in 0.5 mg/ml collagenase and 100 mg/ml
DNase I in RPMI 1640 medium (Invitrogen, Grand Island, NY)
containing 0.5% heat-inactivated fetal calf serum (PAA Laborato-
ries, Pasching, Austria) and 20 mM HEPES as previously described
[55,56]. The uteroplacental tissues were digested in a HBSS
solution containing 1 mg/ml collagenase type IV, 0.2 mg/ml
DNase I, 200 U/ml hyaluronidase, and 1 mg/ml bovine serum
albumin/fraction V as previously described [57]. After enzymatic
dissociation of tissues, an aliquot of each organ (bladder, kidney, or
uterus) or undiluted blood was serially diluted in PBS and plated on
LB agar and LB agar containing ampicillin to enumerate bacterial
burden. The number of colonies was indistinguishable on LB agar
and LB agar containing ampicillin.
Analysis of Cellular inflammation
Cell suspensions were washed in FACS buffer and filtered
through a 70 mm nylon filter (Becton Dickinson, Franklin Lakes,
NJ) to remove cellular debris. One mL of ACK lysing buffer
(Invitrogen, Grand Island, NY) was added to the kidney, spleen,
and bone marrow to lyse red blood cells. A discontinuous 20, 40,
and 80% Percoll gradient was prepared as described [58]
according to manufacturers recommendations (GE Healthcare
Biosciences, Pittsburgh, PA). One ml of single cell suspensions of
kidneys and uterus were underlayed in 80% Percoll layer and
centrifuged at 5006g for 25 min at room temperature. The band
between the 40 and 80% layer was collected and washed twice in
PBS. Prior to antibody staining, single cell suspensions of each
sample were incubated with Fc blocking antibody (eBiosciences,
San Diego, CA), to minimize non-specific antibody staining. The
following antibodies were used to discern specific cellular
populations: anti-CD11b-phycoerythrin (M1/70), anti-Gr-1-phy-
coerythrin-cy-5.5 (RB6-8C5), anti-Ly6C-Alexaflour 488 (ER-
MP20), anti-CD11c-allophycocyanin (N418), anti-major histo-
compatibility complex class II-Alexa 700 (M5/114.15.2), anti-
major histocompatibility complex class II-Biotin (KH74), anti-
allophycocyanin-cy-7 streptavidin, anti-F4-80-phycoerythrin-cy-7
(BM8) (all from eBiosciences, San Diego, CA except anti-MHC II
–Biotin, BD Pharmingen, San Diego, CA). Single color controls
for each antibody were used with either bone marrow or spleen for
fluorescence compensation. A viability discrimination marker was
used according to the manufacturers’ instructions (Violet Live/
Dead kit, Invitrogen, Carlsbad, CA) to exclude dead cells from
subsequent analysis. Cellular data were collected with a BD LSR
II flow cytometer (Becton Dickinson, San Jose, CA) and analyzed
with Flowjo software (Tree Star, Ashland, OR). Statistical analysis
and graph constructions were made using Prism 5.0 (GraphPad
Software, Inc, La Jolla, CA).
Bacterial Cultures
Each organ sample, including blood, was plated on LB plates
containing ampicillin sulfate (125 mg/ml, Fischer Scientific, Fair-
lawn, NJ). Serial dilutions of each organ were plated in consecutive
rows on LB agar and LB agar containing ampicillin to enumerate
bacterial burden. Undiluted blood samples were also plated.
Colony counts were then recorded for any growth and labeled as
none detected if no growth was witnessed. The number of colonies
was indistinguishable on LB agar and LB agar containing
ampicillin.
UPEC Cystitis Provokes Adverse Perinatal Outcomes
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33897Cytokine Analysis
Maternal serum was analyzed for various cytokine levels using a
Th1/Th2 and a Mouse Inflammation Cytokines Bead Arrays (both
from BD Biosciences, San Jose, CA). Samples taken at the time of
harvest from severed renal vessels were spun for 10 minutes at
10,000 rpm. Serum was then collected and frozen at 280uCf o rb a t c h
testing. Fifty microliters of serum was used for each sample tested. If
more than 50 ml was available, samples were run in duplicate. We
then used an LSR II cytometer to measure the following: IL-2, IL-4,
IL-5, IL-6, IL-10, IL-12, IL-17, IFN-c,a n dT N F - a. Software included
in the kits was used for conversion into pg/ml.
mRNA Extraction
Samples of the placenta and the uterus were taken on gestational
day16from4mice.Twomice receivedexperimentalUTIorshame
inoculation on gestational day 14. Tissue samples were homoge-
nized in 1 ml TRIZOLH Reagent per 50–100 mg of tissue using
power homogenizer Polytron. The homogenized samples were
incubated for 5 minutes at room temperature and then 0.2 ml of
chloroform per 1 ml of Trizol were added to the tube. Total RNA
was isolated from the homogenized samples with TRIZOL reagent
according to the manufacturer’s recommendations.
Microarray analysis
Two-color gene expression analysis was performed in-house by
the Biomedical Genomics Core. In outline, 500 ng of total RNA
was amplified and labeled with either Cy3 (uninfected control
samples, n=2) or Cy5 (infected test sample, n=2) using the Low
Linear Amplification Kit (Agilent Technologies, CA). This
labeling reaction produced 7–10.0 mg of Cy3-labeled cRNA
(anti-sense), by first converting mRNA primed with an oligo
(d)T-T7 primer into dsDNA with MMLV-RT and then
amplifying the sample using T7 RNA Polymerase in the presence
of Cy3-CTP. After purification, 825 ng of each the test and
control cRNA was fragmented and co-hybridized to the Whole
Mouse Genome Oligo Microarray (AMADID 04868; Agilent
Technologies, CA) array for 17 hr. at 65uC. This array consists of
44,000 60-mer oligonucleotides, representing 21,609 known genes
represented by 33,661 transcripts.
Microarray slides were washed and then scanned with an
Agilent G2505C Microarray Scanner. Images were analyzed with
Feature Extraction 10.7 (Agilent Technologies, CA) in two color
gene expression mode. Median foreground intensities were
obtained for each spot and imported into the mathematical
software package ‘‘R’’. The intensities were corrected for the
scanner offset but not further background corrected. The dataset
was filtered to remove positive control elements. Using the
negative controls on the arrays, the background threshold was
determined and all values less than this value were set to the
threshold value. Finally, the data were global loess normalized
using the LIMMA microarray processing package in ‘‘R’’ (Smyth,
2004). Fold change values were then calculated for each element
on the array and averaged for the replicate samples. Genes with a
fold change .2 fold up or down were considered differentially
expressed. All microarray data is MIAME compliant and the raw
transcriptional data has been deposited into the MIAME
compliant database, GEO, accession number GSE32028.
Statistical Analysis:
Exact values (symbols) or median values (graphs) are represent-
ed in each figure. Statistical significance was determined using
two-tailed non-parametric Mann-Whitney U test (GraphPad
Software, Inc, La Jolla, CA).
Supporting Information
Figure S1 Maternal weight gain during UTI. Mothers
were weighed daily following impregnation to validate pregnancy.
On gestational day 14, mothers received PBS (black lines) or
experimental UTI (gray lines) and were weighed at least every
other day to assess the effect of UTI on maternal weight gain. The
rate of gain (slope of the line) are not different between the cohorts.
Only three representative mothers from the sham cohort and 7 of
the UTI cohort are depicted for clarity.
(TIF)
Figure S2 Gating strategy for identification of infiltrat-
ing myeloid cells. Representative graphs indicate the markers
and the populations that were selected for analysis.
(TIF)
Figure S3 Correlation of PMN infiltration with IUGR.
The magnitude of PMN infiltration into the uteroplacental tissues
was inversely correlated with the weight of each offspring at
96 hours in pregnant mice that received experimental UTI (gray)
or sham infection (black). Each data point represents the weight of
a single fetus with the magnitude of the PMN infiltration into the
uteroplacental tissues.
(TIF)
Figure S4 Correlation of IL-6 with IUGR. The magnitude
of IL-6 serum levels was inversely correlated with the weight of
each offspring at 96 hours in pregnant mice that received
experimental UTI (gray) or sham infection (black). Each data
point represents the weight of a single fetus with the magnitude of
the maternal circulatory IL-levels.
(TIF)
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